This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
May 18, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty global pharmaceutical company, announced today that
Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference on
Wednesday, May 30, 2012 at
4:00PM Eastern Time at the Waldorf-Astoria Hotel in
New York, New York. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at
http://ir.watson.com. The webcast can also be accessed at the following URL:
An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.
About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. The Company is also developing biosimilar products in Women's Health and Oncology. Additionally, Watson distributes generic and branded pharmaceuticals through its Anda, Inc. distribution business. Watson has operations in many of the worlds established and growing international markets.
For press release and other company information, visit Watson Pharmaceuticals' Web site at
Lisa DeFrancesco (862) 261-7152
Charlie Mayr(862) 261-8030
SOURCE Watson Pharmaceuticals, Inc.